Tunisia

7 Vaccines Approved for Use in Tunisia

RNA

Pfizer/BioNTech

Comirnaty

Approved in 146 countries
80 trials in 26 countries
Approval Source: santetunisie.rns.tn
Non Replicating Viral Vector

Gamaleya

Sputnik Light

Approved in 26 countries
7 trials in 3 countries
Approval Source: reuters.com
Non Replicating Viral Vector

Gamaleya

Sputnik V

Approved in 74 countries
24 trials in 7 countries
Approval Source: tass.com
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Approval Source: sauve.tn
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 140 countries
63 trials in 30 countries
Approval Source: aa.com.tr
Inactivated

Sinopharm (Beijing)

Covilo

Approved in 91 countries
29 trials in 12 countries
Approval Source: xinhuanet.com
Inactivated

Sinovac

CoronaVac

Approved in 56 countries
37 trials in 9 countries
Approval Source: xinhuanet.com

1 in Clinical Trials in Tunisia

DNA

Inovio

INO-4800

9 trials in 9 countries